Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04751877
Title Study of Isatuximab+Lenalidomide+Dexamethasone With/Without Bortezomib in de Novo Non Frail NTE Multiple Myeloma Elderly Patients (IFM2020-05)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Poitiers University Hospital

multiple myeloma


Dexamethasone + Isatuximab + Lenalidomide

Bortezomib + Dexamethasone + Isatuximab + Lenalidomide

Age Groups: senior
Covered Countries

No variant requirements are available.